Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.51% |
| 2 | Consumer Discretionary | 7.62% |
| 3 | Energy | 7.06% |
| 4 | Technology | 6.57% |
| 5 | Industrials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONXX
201
CALL
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $64.8M | 0.1% |
519,800
+453,000
| +678% | +$57.4M |
|
202
East-West Bancorp
EWBC
$18.2B
| $64.5M | 0.1% |
2,018,232
+99,726
| +5% | +$3.02M |
|
|
ARUN
203
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $64.4M | 0.1% |
3,869,778
+1,364,361
| +54% | +$23.8M |
|
204
AMC Global Media
AMCX
$486M
| $64.1M | 0.1% |
936,319
+209,644
| +29% | +$13.9M |
|
205
Berkshire Hathaway Class B
BRK.B
$1.11T
| $63.9M | 0.1% |
562,996
+26,214
| +5% | +$3.02M |
|
206
Designer Brands
DBI
$321M
| $63.8M | 0.1% |
1,495,590
+603,236
| +68% | +$24.4M |
|
207
CALL
Herbalife
HLF
$1.23B
| $63.8M | 0.1% |
1,827,600
+1,457,400
| +394% | +$45.1M |
|
208
DuPont de Nemours
DD
$19.5B
| $63.7M | 0.1% |
+655,078
| New | +$61M |
|
|
YHOO
209
CALL
DELISTED
Yahoo Inc
YHOO
| $63.7M | 0.1% |
1,920,800
+834,900
| +77% | +$23.6M |
|
|
FINL
210
DELISTED
Finish Line
FINL
| $63.6M | 0.1% |
2,557,940
+1,150,321
| +82% | +$25.5M |
|
|
CXO
211
DELISTED
CONCHO RESOURCES INC.
CXO
| $63M | 0.1% |
579,114
+303,066
| +110% | +$28.9M |
|
212
AB InBev
BUD
$159B
| $62.3M | 0.09% |
628,030
+594,394
| +1,767% | +$56.6M |
|
|
BNY
213
Bank of New York Mellon
BNY
$109B
| $62.2M | 0.09% |
2,061,026
+1,677,507
| +437% | +$51.5M |
|
214
PUT
Intuitive Surgical
ISRG
$142B
| $61.7M | 0.09% |
1,475,100
+347,400
| +31% | +$15.3M |
|
|
RATE
215
DELISTED
Bankrate Inc
RATE
| $61.2M | 0.09% |
2,976,523
-1,159,424
| -28% | -$19.9M |
|
216
PUT
Chevron
CVX
$386B
| $61.2M | 0.09% |
503,800
+222,300
| +79% | +$27.3M |
|
217
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $61.1M | 0.09% |
195,400
+54,900
| +39% | +$14.4M |
|
|
218
PUT
Visa
V
$677B
| $60.8M | 0.09% |
1,273,600
+501,600
| +65% | +$23.2M |
|
219
Capital One
COF
$134B
| $60.8M | 0.09% |
884,986
+285,998
| +48% | +$19.2M |
|
|
FNSR
220
DELISTED
Finisar Corp
FNSR
| $60.6M | 0.09% |
+2,678,698
| New | +$55.2M |
|
|
AWH
221
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $60.5M | 0.09% |
1,827,150
-1,049,349
| -36% | -$33M |
|
222
Devon Energy
DVN
$49.9B
| $60.5M | 0.09% |
1,047,786
+805,402
| +332% | +$46M |
|
223
CALL
Procter & Gamble
PG
$338B
| $60.5M | 0.09% |
800,400
+325,800
| +69% | +$25.9M |
|
224
NOV
NOV
$7.49B
| $60.5M | 0.09% |
858,975
+100,178
| +13% | +$6.7M |
|
225
PUT
Johnson & Johnson
JNJ
$626B
| $60.4M | 0.09% |
697,300
+169,400
| +32% | +$15.2M |
|
Similar funds
Ken Griffin's Q3 2013 Portfolio in Review
As of Q3 2013, Ken Griffin held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ken Griffin's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.
- Ken Griffin's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Ken Griffin added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Ken Griffin's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Ken Griffin fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Ken Griffin's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Ken Griffin opened 735 new positions and closed 505 in Q3 2013.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.